Sorrel Medical develops and manufactures wearable drug-delivery devices designed to optimize the patient experience and the value for pharmaceutical companies. Sorrel's digitally integrated platform is intended for subcutaneous delivery of injectable drugs, biologics, and biosimilars and is suited for multiple configurations, molecules, and indications. The company's partnerships provide core strengths in device R&D, regulation, and manufacturing and leverage experience from the Eitan Group to bring drug-delivery devices to market. Sorrel Medical is part of the Eitan Group.